DOXY-SLEEP-AID Drug Patent Profile
✉ Email this page to a colleague
When do Doxy-sleep-aid patents expire, and when can generic versions of Doxy-sleep-aid launch?
Doxy-sleep-aid is a drug marketed by Par Pharm and is included in one NDA.
The generic ingredient in DOXY-SLEEP-AID is doxylamine succinate. There are fourteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the doxylamine succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Doxy-sleep-aid
A generic version of DOXY-SLEEP-AID was approved as doxylamine succinate by PERRIGO on September 18th, 1996.
Summary for DOXY-SLEEP-AID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 95 |
| Patent Applications: | 1,477 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DOXY-SLEEP-AID at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DOXY-SLEEP-AID
US Patents and Regulatory Information for DOXY-SLEEP-AID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Pharm | DOXY-SLEEP-AID | doxylamine succinate | TABLET;ORAL | 070156-001 | Jul 2, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
